Literature DB >> 16301684

Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha.

Joseph Cantor1, Kathryn Haskins.   

Abstract

Effector function of T cells in autoimmune diabetes has been widely studied with mixed populations of lymphoid T cells stimulated ex vivo, but this approach does not permit evaluation of the contribution by a single T cell clone in the inflammatory site during pathogenesis. We have investigated cytokine production both in vitro and in vivo in a panel of diabetogenic CD4 Th1 T cell clones derived from the NOD mouse. SuperArray analysis showed a common pattern of mRNA expression for inflammatory cytokines and receptors in vitro after TCR stimulation. Ex vivo intracellular cytokine staining demonstrated that two important inflammatory cytokines, IFN-gamma and TNF-alpha, were being made by these T cells recovered from the pancreas 6 days following adoptive transfer. TNF-alpha produced in the pancreas by pathogenic T cell clones and recruited macrophages was not the membrane-bound form. Secreted TNF-alpha can lead to production of multiple inflammatory chemokines, as were observed in the pathogenic clones by intracellular cytokine staining. Our results not only define the nature of an inflammatory cytokine response critical to development of diabetes, but also suggest its role in the regulation of other events during pathogenesis induced by CD4 T cells. Similar analyses in other models demonstrated that disease induced by CD4 T cell clones closely resembles spontaneous autoimmune diabetes in which both CD4 and CD8 T cells are required. Thus, cloned T cells in effect amplify effector function of T cells which otherwise may be difficult to detect without ex vivo stimulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301684     DOI: 10.4049/jimmunol.175.11.7738

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Anti-tumor immunostimulatory effect of heat-killed tumor cells.

Authors:  Taek Joon Yoon; Ji Yeon Kim; Hyojeong Kim; Changwan Hong; Hyunji Lee; Chang Kwon Lee; Kwang Ho Lee; Seokmann Hong; Se Ho Park
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

Review 2.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

3.  A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice.

Authors:  Ming S Lin; Hubert M Tse; Meghan M Delmastro; Suzanne Bertera; Caterina T Wong; Robert Lakomy; Jing He; Martha M Sklavos; Gina M Coudriet; Massimo Pietropaolo; Massimo M Trucco; Jon D Piganelli
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

4.  Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic mice.

Authors:  Maria C Seleme; Weiqi Lei; Ashley R Burg; Kah Yong Goh; Allison Metz; Chad Steele; Hubert M Tse
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

5.  Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity.

Authors:  Joseph Cantor; Marina Slepak; Nil Ege; John T Chang; Mark H Ginsberg
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

Review 6.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28

7.  Decreasing TNF-alpha results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis.

Authors:  Kemin Chen; Yongzhong Wei; Gordon C Sharp; Helen Braley-Mullen
Journal:  J Leukoc Biol       Date:  2006-10-17       Impact factor: 4.962

8.  Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice.

Authors:  Rocky L Baker; Thomas Delong; Gene Barbour; Brenda Bradley; Maki Nakayama; Kathryn Haskins
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

9.  Pathogenicity of T helper 2 T-cell clones from T-cell receptor transgenic non-obese diabetic mice is determined by tumour necrosis factor-alpha.

Authors:  Jing He; Kathryn Haskins
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

Review 10.  Parasitic helminths: new weapons against immunological disorders.

Authors:  Yoshio Osada; Tamotsu Kanazawa
Journal:  J Biomed Biotechnol       Date:  2010-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.